Treatment with flonoltinib maleate produced significant, durable reductions in splenomegaly and improved symptom response for patients with myelofibrosis, according to data from a first-in-human phase 1/2a study.
@ASH_hematology #ASH24 #mpnsm #hematology
#ash24
#ASH24 #mpnsm #hematology